Literature DB >> 8230458

Replication of lymphocytic choriomeningitis virus is restricted in terminally differentiated neurons.

J C de la Torre1, G Rall, C Oldstone, P P Sanna, P Borrow, M B Oldstone.   

Abstract

We have investigated the replication of lymphocytic choriomeningitis virus (LCMV) before and after the nerve growth factor (NGF)-induced transdifferentiation of PC12 cells from the chromaffin to the neuron-like phenotype. Untreated and NGF-treated cells were equally susceptible to LCMV infection; however, the viral yield was found to be 1,000-fold lower in NGF-differentiated PC12 cells. The reduced viral yield correlated with restricted LCMV replication and transcription within the infected cell, which was not caused by the lack of cell proliferation in the NGF-treated cells but rather was related to the induction or changes in expression levels of specific gene product(s) associated with the cell commitment to a neuronal phenotype. The return to the chromaffin phenotype after withdrawal of NGF restored normal LCMV yields as well as levels of viral replication and transcription. The finding of reduced viral replication in terminally differentiated neuronal cells has important implications for understanding the mechanism by which neurotropic viruses, such as LCMV, are able to establish a long-term persistent infection in the central nervous system in the absence of severe pathological changes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230458      PMCID: PMC238199     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Regulation of ppp(A2'p)nA-dependent RNase levels during interferon treatment and cell differentiation.

Authors:  D Krause; R H Silverman; H Jacobsen; S A Leisy; C W Dieffenbach; R M Friedman
Journal:  Eur J Biochem       Date:  1985-02-01

2.  Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles.

Authors:  N J DePolo; C Giachetti; J J Holland
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

3.  Constitutive expression of a 2',5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression.

Authors:  G Rysiecki; D R Gewert; B R Williams
Journal:  J Interferon Res       Date:  1989-12

4.  Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.

Authors:  M B Oldstone; P Blount; P J Southern; P W Lampert
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

Review 5.  Persistence of RNA viruses in the central nervous system.

Authors:  K Kristensson; E Norrby
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

Review 6.  The mode of action of nerve growth factor in PC12 cells.

Authors:  A Levi; S Biocca; A Cattaneo; P Calissano
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

Review 7.  Strategies of virus persistence.

Authors:  B W Mahy
Journal:  Br Med Bull       Date:  1985-01       Impact factor: 4.291

8.  Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination.

Authors:  A Wille; A Gessner; H Lother; F Lehmann-Grube
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

9.  Modulation of herpes simplex virus (HSV) infection of cultured neuronal cells by nerve growth factor and antibody to HSV.

Authors:  G B Clements; P G Kennedy
Journal:  Brain       Date:  1989-10       Impact factor: 13.501

10.  Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells.

Authors:  M E Greenberg; L A Greene; E B Ziff
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

View more
  6 in total

1.  Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence.

Authors:  Ana Grande-Pérez; Gema Gómez-Mariano; Pedro R Lowenstein; Esteban Domingo
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth.

Authors:  Ryan D Michalek; S Troy Pellom; Beth C Holbrook; Jason M Grayson
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

3.  Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production.

Authors:  D M Lawrence; C E Patterson; T L Gales; J L D'Orazio; M M Vaughn; G F Rall
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence.

Authors:  C F Evans; P Borrow; J C de la Torre; M B Oldstone
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

5.  Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection.

Authors:  Henning Lauterbach; Elina I Zuniga; Phi Truong; Michael B A Oldstone; Dorian B McGavern
Journal:  J Exp Med       Date:  2006-07-17       Impact factor: 14.307

Review 6.  Virus demyelination.

Authors:  John K Fazakerley; Robert Walker
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.